The CDC RLD macaque model is currently one of the best available animal models for using relevant mucosal SHIV/SIV challenge to mimic in vivo HIV exposure in humans. Unlike other DAIDS resources, safety/efficacy testing and pharmacokinetic/pharmacodynamic evaluations can be conducted in the same model. Through access to this CDC model DAIDS will be able to enable important gap-filling preclinical studies and ensure that shared resources are used towards a common goal, i.e. the advancement of the best topical microbicide/biomedical prevention candidates to clinical trials.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$2,500,000
Indirect Cost
City
State
Country
Zip Code